Minerva anestesiologica最新文献_第8页

Intercostobrachial neuralgia after surgery for acromioclavicular joint dislocation with occult rib fractures. 肩锁关节脱位伴隐匿性肋骨骨折术后肋间臂神经痛。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 Epub Date: 2025-01-30 DOI: 10.23736/S0375-9393.24.18508-2

Bang-Jiang Wen, Wen-Yi Gong, Nai-Yu Yu, Chen-Guang Li, Kun Fan

引用次数: 0

BRILMA block for analgesia in adolescent fibroadenoma excision. BRILMA 阻滞术用于青少年纤维腺瘤切除术的镇痛。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 Epub Date: 2024-10-31 DOI: 10.23736/S0375-9393.24.18552-5

Volkan Özen, Engin I Turan, Arda Ayas, Taylan Kirdan

引用次数: 0

Evaluating the safety and efficacy of repeated spinal anesthesia in multiple lower extremity surgeries: a case series of four patients. 评估多次下肢手术中重复脊髓麻醉的安全性和有效性：四例患者的病例系列。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 Epub Date: 2024-10-31 DOI: 10.23736/S0375-9393.24.18498-2

Abdurrahman E Baydemir, Engin I Turan, Ezgi Saçak, Funda G Özcan

引用次数: 0

Adopting the official name in scientific literature. 在科学文献中采用正式名称。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 Epub Date: 2024-10-31 DOI: 10.23736/S0375-9393.24.18507-0

Burhan Dost

引用次数: 0

Comparison of remimazolam and propofol on postoperative subjective quality of recovery in patients undergoing general anesthesia: a meta-analysis of randomized controlled trials. 比较瑞马唑仑和异丙酚对全身麻醉患者术后主观恢复质量的影响：随机对照试验荟萃分析。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 Epub Date: 2024-11-20 DOI: 10.23736/S0375-9393.24.18395-2

Ru-Ting Xue, Ran-Hong Sun, Min Wang, Hao Guo, Jie Chang

{"title":"Comparison of remimazolam and propofol on postoperative subjective quality of recovery in patients undergoing general anesthesia: a meta-analysis of randomized controlled trials.","authors":"Ru-Ting Xue, Ran-Hong Sun, Min Wang, Hao Guo, Jie Chang","doi":"10.23736/S0375-9393.24.18395-2","DOIUrl":"10.23736/S0375-9393.24.18395-2","url":null,"abstract":"Introduction: Remimazolam, a recently approved drug for surgical sedation and general anesthesia, has been compared with propofol in previous studies regarding its efficacy as a general anesthetic. However, the question of whether remimazolam demonstrates non-inferiority to propofol in postoperative subjective quality of recovery (QoR) among patients under general anesthesia has not been definitively answered.Evidence acquisition: PubMed, Embase, and Cochrane Library databases were systematically searched for all published randomized controlled trials (RCTs) comparing the efficacy of remimazolam and propofol. The primary outcome assessed was the quality of recovery (QoR-15, QoR-40) on postoperative days (POD) 1-3. Secondary outcomes included the duration until consciousness recovery, extubation time, incidence of postoperative nausea and vomiting (PONV), and length of hospital stay.Evidence synthesis: The analysis involved 10 RCTs with a total of 1077 patients. Remimazolam showed comparable QoR scores to propofol on POD1 (nine trials, standardized mean difference [SMD]: 0.14, 95% confidence interval [CI]: -0.15 to 0.44, P=0.34), POD 2 (two trials, SMD: 0.09, 95% CI: -0.18 to 0.36, P=0.5), and POD 3 (four trials, SMD: 0.17, 95% CI: -0.51 to 0.85, P=0.62). Subgroup and sensitivity analyses confirmed the robustness of these findings. Furthermore, no significant differences were observed in recovery time for consciousness, extubation duration, incidence of PONV, or length of hospital stay between the remimazolam and propofol groups.Conclusions: Remimazolam is similar to propofol in terms of postoperative subjective QoR for patients receiving general anesthesia.","PeriodicalId":18522,"journal":{"name":"Minerva anestesiologica","volume":" ","pages":"191-200"},"PeriodicalIF":2.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparison of dexmedetomidine, ketamine, and magnesium sulfate for the prevention of emergence agitation following sevoflurane-based anesthesia in pediatric cardiac catheterization. 比较右美托咪定、氯胺酮和硫酸镁在小儿心脏导管术中基于七氟醚的麻醉后防止出现躁动的效果。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 Epub Date: 2024-11-12 DOI: 10.23736/S0375-9393.24.18306-X

Passaint F Hassan, Amany H Saleh

{"title":"Comparison of dexmedetomidine, ketamine, and magnesium sulfate for the prevention of emergence agitation following sevoflurane-based anesthesia in pediatric cardiac catheterization.","authors":"Passaint F Hassan, Amany H Saleh","doi":"10.23736/S0375-9393.24.18306-X","DOIUrl":"10.23736/S0375-9393.24.18306-X","url":null,"abstract":"Background: Emergence agitation (EA) is non-purposeful agitation that occurs during the early stages of general anesthesia recovery. This randomized, double-blinded trial aimed to compare the effect of dexmedetomidine, ketamine, and magnesium sulfate on the severity of EA following sevoflurane-based anesthesia in pediatric cardiac catheterization. We examined the fixed doses and assessed the severity of agitation using the Pediatric Anesthesia Emergence Delirium Scale (PAED) score.Methods: One hundred children undergoing heart catheterization without local anesthetic in the skin were randomly divided into four groups. The Dexmedetomidine (D) Group (N.=25) received dexmedetomidine 1 μg/kg IV over 10 min, then 0.5 μg/kg/h. The Magnesium Sulfate (M) Group (N.=25) received 15 mg/k MgSO<inf>4</inf> IV over 10 min and then 10 mg/kg/h. The Ketamine (K) Group (N.=25) received 1 mg/kg ketamine over 10 min, then 1 mg/kg/h. The Control (C) Group (N.=25) received 0.9% saline at the same rate as other groups. All medications were diluted in 50 mL 0.9% saline.Results: The dexmedetomidine group exhibited a 0% incidence of EA, compared to 4% in the ketamine group, 12% in the MgSO<inf>4</inf> group, and 40% in the control groups (P<0.001). Dexmedetomidine significantly reduced the PAED Scale and pain scores compared to the other groups. The effects of ketamine and MgSO<inf>4</inf> on PAED and pain scores were comparable, with both treatments demonstrating significantly lower scores than the control group.Conclusions: Dexmedetomidine exhibited higher efficacy than ketamine and magnesium sulfate in reducing the severity of postoperative EA. However, ketamine and magnesium sulfate demonstrated comparable efficacy, exceeding that of the control group.","PeriodicalId":18522,"journal":{"name":"Minerva anestesiologica","volume":" ","pages":"139-146"},"PeriodicalIF":2.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A year in review in Minerva Anestesiologica 2024: anesthesia, analgesia, and perioperative medicine. 《麻醉学杂志》2024年回顾：麻醉、镇痛和围手术期医学。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 DOI: 10.23736/S0375-9393.25.19034-2

Franco Cavaliere, Massimo Allegri, Alparslan Apan, Luca Brazzi, Massimiliano Carassiti, Edmond Cohen, Pierangelo Di Marco, Olivier Langeron, Marco Rossi, Peter Spieth, David Turnbull, Frank Weber

引用次数: 0

Highlights of the March 2025 issue. 2025年3月刊的亮点。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 DOI: 10.23736/S0375-9393.25.19033-0

Franco Cavaliere

引用次数: 0

Uncontrolled donation after circulatory death in the Tuscany region: evolving paradigms and potentials. An 8-year experience. 托斯卡纳地区循环死亡后不受控制的捐赠：演变的范例和潜力。8年的工作经验。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 DOI: 10.23736/S0375-9393.25.18475-7

Chiara Lazzeri, Manuela Bonizzoli, Davide Ghinolfi, Vincenzo Li Marzi, Luca Luzzi, Lara Entani Santini, Adriano Peris

{"title":"Uncontrolled donation after circulatory death in the Tuscany region: evolving paradigms and potentials. An 8-year experience.","authors":"Chiara Lazzeri, Manuela Bonizzoli, Davide Ghinolfi, Vincenzo Li Marzi, Luca Luzzi, Lara Entani Santini, Adriano Peris","doi":"10.23736/S0375-9393.25.18475-7","DOIUrl":"https://doi.org/10.23736/S0375-9393.25.18475-7","url":null,"abstract":"Background: Uncontrolled DCD (uDCD) represents a potential source of organs since the global survival rates of patients with out of hospital cardiac arrest (OHCA) is estimated less than 10% across all registries. We describe our 8-year experience with the implementation of the uDCD program over the Tuscany Region since June 2016. We focus on feasibility, results (organ transplant) and organizational changes.Methods: The study population included uDCDs assessed in the Tuscany Region from 2016 to 2024. Two different periods were considered: Period 1: from 2016 to 2019; Period 2: from 2020 to 2024 (after COVID pandemic).Results: Overall, 226 potential uDCDs were assessed by the local transplant coordinators, with an increased number in Period 2 in respect to Period 1 (151 vs. 75, 67% vs. 33%). A significant increase in refusals was observed (Period 2: 25% vs. Period 1: 6%, P=0.004). The overall utilization rate was 56%. Fifty-seven kidneys were transplanted, 22 livers and two lungs. The number of organs per donor increased in Period 2 compared to Period 1.Conclusions: According to our 8-year experience, the uDCD proved to be an add-on activity, giving the opportunity to all OHCA patients without survival options to save lives by organ donation. The uDCD only lung program is a feasible chance to organ donate for OHCA patients with no survival possibility in peripheral hospital. The uDCD program, despite its complexity, seems to have potentials ranging to organizational (uDCD only lung program, mobile machine perfusion) to clinical issues (optimizing the donor-recipient match).","PeriodicalId":18522,"journal":{"name":"Minerva anestesiologica","volume":"91 3","pages":"184-190"},"PeriodicalIF":2.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143978539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Anatomical spread of local anesthetic in circumpsoas block: a cadaveric study. 局部麻醉在环腰肌阻滞中的解剖扩散：一项尸体研究。

IF 2.9 3区医学

Minerva anestesiologica Pub Date : 2025-03-01 Epub Date: 2025-01-30 DOI: 10.23736/S0375-9393.24.18521-5

Yunus O Atalay, Elif K Koc, Semih B Sozcu, Bahar Tekin, Gamze Ansen, Gozde Cingoz, Bayram U Sakul, Haci A Alici

引用次数: 0